In conclusion, the increased expression of FBXL18 in HCC patients promoted hepatocarcinogenesis through the induction of RPS15A ubiquitination and upregulation of SMAD3 expression (Fig. 6F). Here, FBXL18 is linked to hepatocellular carcinoma.